Birte Drewes

Dr. Birte Drewes

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
NWNils Walter
Nils Walter
JBJan Bertram
Jan Bertram
BDBirte Drewes
Birte Drewes
VBVictor Bahutski
Victor Bahutski
MTMarco Timmer
Marco Timmer
BZBoris Zlatopolskiy
Boris Zlatopolskiy

1 February 2007 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
PDF file
WSW. Sihver
W. Sihver
BDBirte Drewes
Birte Drewes
ASA. Schulze
A. Schulze
ROR.A. Olsson
R.A. Olsson
HCH.H. Coenen
H.H. Coenen

23 June 2020 in Molecules
Verified
Journal Article
Open access
PDF file
BZBoris Zlatopolskiy
Boris Zlatopolskiy
FNFelix Neumaier
Felix Neumaier
TRTill Rüngeler
Till Rüngeler
BDBirte Drewes
Birte Drewes
NKNiklas Kolks
Niklas Kolks
BNBernd Neumaier
Bernd Neumaier
M1 muscarinic acetylcholine receptors (mAChRs) are abundant in postsynaptic nerve terminals of all forebrain regions and have been implicated in the cognitive decline associated with Alzheimer’s disease and other CNS pathologies. Consequently, major efforts have been spent in the development of subtype-selective positron emission tomography (PET) tracers for mAChRs resulting in the development of several 11C-labeled probes. However, protocols for the preparation of 18F-labeled mAChR-ligands have not been published so far. Here, we describe a straightforward procedure for the preparation of an 18F-labeled M1 mAChR agonist and its corresponding pinacol boronate radiolabeling precursor and the non-radioactive reference compound. The target compounds were prepared from commercially available aryl fluorides and Boc protected 4-aminopiperidine using a convergent reaction protocol. The radiolabeling precursor was prepared by a modification of the Miyaura reaction and labeled via the alcohol-enhanced Cu-mediated radiofluorination. The developed procedure afforded the radiotracer in a non-decay-corrected radiochemical yield of 17 ± 3% (n = 3) and in excellent radiochemical purity (>99%) on a preparative scale. Taken together, we developed a straightforward protocol for the preparation of an 18F-labeled M1 mAChR agonist that is amenable for automation and thus provides an important step towards the routine production of a 18F-labeled M1 selective PET tracer for experimental and diagnostic applications.

10 September 2007 in Journal of Labelled Compounds and Radiopharmaceuticals
Verified
Journal Article
Closed access
PDF file
UKUte B. Kronenberg
Ute B. Kronenberg
BDBirte Drewes
Birte Drewes
WSWiebke Sihver
Wiebke Sihver
HCHeinz H. Coenen
Heinz H. Coenen

22 June 2007 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
BDBirte Drewes
Birte Drewes
WSWiebke Sihver
Wiebke Sihver
SWSabine Willbold
Sabine Willbold
RORay A. Olsson
Ray A. Olsson
HCHeinz H. Coenen
Heinz H. Coenen

24 July 2026 in Polymer Degradation and Stability
Verified
Journal Article
Open access
SASara Adeleh
Sara Adeleh
TBTabea Becker
Tabea Becker
SHSonja Herres-Pawlis
Sonja Herres-Pawlis
RBRoland Bol
Roland Bol
BDBirte Drewes
Birte Drewes
TPThomas Pütz
Thomas Pütz